Willow vs Directmeds: structured support or lower starting price
Willow vs Directmeds is a choice between a telehealth-first oral GLP-1 program built around progress tracking and follow-up support and a clinician-reviewed compounded GLP-1 service with lower advertised starting pricing. Early verdict: choose Willow if you want structured digital follow-up and behavioral scaffolding; choose Direct Meds if you want compounded injectable or sublingual GLP-1 with transparent standard pricing and free next-day shipping.
Explore Willow’s progress tracking program
How Willow and Direct Meds differ at a glance
Both platforms use licensed clinicians and telehealth workflows and note that treatment is available only when a licensed clinician determines it is medically appropriate. They differ in format, pricing presentation, support emphasis, and shipping and cancellation terms.
| Criteria | Willow | Direct Meds |
|---|---|---|
| Primary offering | Oral GLP-1 with progress tracking and follow-up | Compounded semaglutide and tirzepatide in injectable and sublingual formats |
| Starting price | Starting price 299 | Starting at 147; FAQ lists standard semaglutide 297/mo and tirzepatide 399/mo |
| Care model emphasis | Structured weight management journey with follow-up support | Clinician-reviewed medication with ongoing clinician and nursing support |
| Shipping and supplies | Not verified on captured page | Medication, supplies and free next-day UPS/FedEx shipping included |
| Fees and cancellation | Not verified on captured page | No monthly membership fee; month-to-month cancellation; subscribe-and-save plans require stated term |
| Regulatory note | Compounded medications, when offered, are not FDA-approved | Compounded medications are not FDA-approved and not reviewed by FDA |
1. Treatment format and clinical focus
Willow positions its oral GLP-1 program as a structured weight management journey that emphasizes progress tracking tools and follow-up consultations. Direct Meds offers clinician-reviewed compounded semaglutide and tirzepatide in injectable and sublingual forms with clinician and nursing support. The providers both rely on licensed telehealth teams, but Willow emphasizes behavioral scaffolding while Direct Meds emphasizes multiple medication formats.
2. Pricing and promotions
Direct Meds advertises starting at 147 and a summer promotion saving 150, while its FAQ lists standard pricing of semaglutide 297 per month and tirzepatide 399 per month. Willow’s captured evidence shows a starting price of 299. The evidence notes that Direct Meds has promotional pricing and separate standard FAQ prices. Do not assume additional discounts or terms beyond those stated.
See Direct Meds pricing and formats
3. Support, tracking and follow-up
Willow highlights progress tracking tools and follow-up consultations as core features, describing the program as converting GLP-1 efficacy into sustainable outcomes through a structured support model. Direct Meds advertises ongoing clinician and nursing support but focuses on medication delivery and supplies. If ongoing digital tracking is a priority, Willow is presented as built around that offering.
4. Shipping, fees and cancellation
Direct Meds includes medication, clinician review, telehealth visits, supplies and free next-day UPS/FedEx shipping in its captured evidence, states no monthly membership fee, and offers month-to-month cancellation for some plans. Willow’s captured page did not verify shipping, fees, membership or cancellation details. These specific Direct Meds terms may matter for patients who prioritize shipping speed and clear cancellation policies.
5. Regulatory and safety notes
Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment with either provider is available only when a licensed clinician determines it is medically appropriate. Medication-specific approval status must be confirmed where applicable.
Review Willow’s clinician review and tracking
Comparison summary
Willow vs Directmeds contrast chiefly on program structure and format, pricing communication, shipping and cancellation transparency, and the presence of digital progress tracking. Willow centers on an oral GLP-1 pathway with structured follow-up and progress tracking. Direct Meds centers on compounded injectable and sublingual options with promotional starting pricing, included supplies and free next-day shipping.
Start with Willow’s structured program
Choose one based on what matters most
Choose Willow if you want a telehealth-first oral GLP-1 program that emphasizes progress tracking tools and follow-up consultations as part of a structured weight management journey. Choose Direct Meds if you want clinician-reviewed compounded injectable or sublingual semaglutide or tirzepatide with a promotional starting price, included supplies and free next-day shipping, and no separate monthly membership fee.
For both providers, treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.